Project Grant R44GM148138

Award Date 9/17/22
Completion Date 8/31/24
Dollars Obligated $2.7M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $349,566 to Biosensing Instrument Inc. to develop a Spotting-Free Nano-Oscillator Array (SFNOA) technology for high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The SFNOA technology integrates several innovative techniques, including virion-displayed transmembrane...
Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...
The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a 3-year, $450,000 Project Grant to The Washington University to develop a novel "Plasmon-Enhanced Expansion Fluorospot" (PEEFS) technology. This bioplasmonic imaging method combines fluorescent nanoparticles and expansion microscopy to enable highly sensitive and high-resolution monitoring of cell-secreted proteins at the single-cell level. Key project objectives...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $986,651 to Auragent Bioscience LLC (doing business as Brightest Bio) to develop an ultrabright fluorescent reagent called a Plasmonic Fluor (PF). The PF technology is designed to significantly enhance the detection sensitivity of fluorescent Western blot assays, enabling more precise protein concentration measurements and...
This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...
This National Science Foundation (NSF) Project Grant award for $380,074, awarded on September 1, 2024, aims to develop a platform for instrument-free, easy-to-interpret quantitative analysis of molecular biomarkers. The project will produce a general methodology adaptable to a range of molecular targets, including potential new agents. The key products to be delivered include: A "yes/no" output for quantitative measurement, enabled through stoichiometry and negative cooperativity-based...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training provides $350,000 to Fluidispec LLC to develop a new microfluidic/nanofluidic sample preparation platform. The goal is to improve single-cell and low-input proteomics analysis by enabling efficient extraction of proteins from cells, removal of contaminants, and improved protein denaturation. This platform is expected to enhance...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $350,000 to Electronic Biosciences, Inc. to develop and demonstrate a novel enzyme-based, single-molecule protein sequencing system. The innovative platform aims to leverage enzyme-driven processing and sequencing of individual proteins and peptides, combined with advanced bioinformatics, to achieve high accuracy and...

HIGH PERFORMANCE AND WIDELY ACCESSIBLE SECRETOMICS ASSAY PLATFORM - ABSTRACT SECRETORY PROTEINS ARE FUNDAMENTAL TO LOCAL AND SYSTEMIC CELLULAR SIGNALING IN BIOLOGICAL SYSTEMS. THE REGULATION AND DYSREGULATION OF THE NETWORKS INVOLVING THESE PROTEINS PLAYS A CRITICAL ROLE IN HEALTH, AGING, AND DEVELOPMENT OF DISEASE. AS SUCH, STUDY OF THESE PROTEINS AND THEIR NETWORKS IS CRITICAL TO OUR UNDERSTANDING OF BIOLOGY. NOT SURPRISINGLY, THIS PARTICULAR SET OF PROTEINS CONSTITUTES A LARGE PROPORTION OF THE TARGETS OF PHARMACEUTICAL DRUGS, AND ALSO REPRESENTS ATTRACTIVE TARGETS FOR DIAGNOSTICS AND FUTURE PRECISION MEDICINE EFFORTS. UNFORTUNATELY, MANY OF THESE SECRETED PROTEINS ARE DIFFICULT TO DETECT. THERE ARE EXISTING TECHNOLOGIES FOR STUDYING THESE SECRETED PROTEINS BUT THEY EITHER UNDERPERFORM, ARE EXTREMELY EXPENSIVE AND/OR COMPLEX GIVEN THEIR SPECIFIC-UTILITY. CONTAINING MULTIPLE CELL TYPES. ALTHOUGH THE NEED TO STUDY SECRETED PROTEINS IS UBIQUITOUS, THERE IS NOT A TECHNOLOGY THAT IS WIDELY AVAILABLE (INEXPENSIVE) AND CAPABLE OF PROVIDING INFORMATION ON MULTIPLE SECRETED PROTEINS SIMULTANEOUSLY AT SINGLE-CELL RESOLUTION, AND WE AIM TO ADDRESS THIS NEED IN THE CURRENT PROJECT. AT THE CORE OF OUR TECHNOLOGIES IS THE PLASMONIC FLUOR (PF), OUR PROPRIETARY, ULTRABRIGHT FLUORESCENT NANOCONSTRUCT DESIGNED TO ENHANCE THE PERFORMANCE OF FLUORESCENCE-BASED IMMUNOASSAYS. WE HAVE ALREADY BUILT A HIGH-SENSITIVITY, MULTIPLEXED IMMUNOASSAY PLATFORM LEVERAGING THIS TECHNOLOGY, WHICH IS CURRENTLY BEING TESTED WITH EXTERNAL COLLABORATORS. THIS PLATFORM INCLUDES AN INEXPENSIVE, HIGH PERFORMANCE, SINGLE-LASER FLUORESCENCE MICROPLATE/SLIDE READER OPTIMIZED FOR USE WITH OUR PFS. WE WILL EXTEND THIS EXISTING PLATFORM TO ACCOMMODATE PF- ENHANCED CELLULAR SECRETION ASSAYS WE CALL PFLUOROSPOT. THE UPGRADED PLATFORM THAT WILL RESULT FROM THE PROPOSED EFFORT WILL BE A TRULY VERSATILE AND POWERFUL TOOL FOR THE MEASUREMENT OF PROTEINS. IN OUR PRELIMINARY WORK, WE HAVE SUCCESSFULLY MANUFACTURED AT COMMERCIAL SCALE AND WITH HIGH REPRODUCIBILITY STREPTAVIDIN-CONJUGATED PFS THAT ARE SPECTRALLY EQUIVALENT TO FITC, CY3, AND CY5 (PF490, PF550, AND PF650, RESPECTIVELY). WE HAVE ALSO CREATED THREE PFS WITH ENTIRELY UNIQUE EXCITATION/EMISSION SPECTRA: TWO WHICH HAVE EXCITATION SPECTRA LIKE FITC AND EMIT LIKE CY3 AND CY5 (PF490_550 AND PF490_650, RESPECTIVELY), AND ONE WHICH HAS AN EXCITATION SPECTRUM LIKE CY3 BUT EMITS LIKE CY5 (PF550_650). THESE UNIQUE PFS WERE SYNTHESIZED AT A PROTOTYPE SCALE WHICH WE AIM TO SCALE UP IN THIS EFFORT BECAUSE THEY WILL ALLOW 3 LASERS TO BE USED TO INTERROGATE 6 SEPARATE TARGETS. IN A DEMONSTRATION OF APPLICABILITY TO CELLULAR SECRETION ASSAYS, STREPTAVIDIN-PF550 AND PF650 WERE CONJUGATED TO ANTIBODIES AT A SMALL SCALE AND USED TO PERFORM DUAL-COLOR PFLUOROSPOT. THESE INITIAL PFLUOROSPOT EXPERIMENTS SHOW THAT ADDITIONAL INFORMATION CAN BE OBTAINED IN THESE ASSAYS RELATIVE TO ELISPOT/FLUOROSPOT, AND ARE SIMPLER AND SIGNIFICANTLY FASTER TO PERFORM. IT WAS POSSIBLE TO VISUALIZE INDIVIDUAL CELLS FOR ADHERENT CELLS AND BETTER LOCALIZE SECRETING CELLS. THIS IS PARTICULARLY IMPORTANT FOR UNDERSTANDING HETEROGENEITY, SPATIAL EFFECTS IN CO-CULTURE, AND POLYFUNCTIONALITY, AND WE PROPOSE TO ADD A 4TH LASER TO OUR READER TO ACCOMMODATE CELL MARKERS. ADDITIONALLY, A SINGLE-COLOR PFLUOROSPOT ASSAY WAS READ WITH OUR EXISTING READER AND DEMONSTRATED HIGH SENSITIVITY, HIGH RESOLUTION, AND SHORT READ TIMES. WE BELIEVE OUR PFLUOROSPOT PLATFORM AND READER WILL BECOME THE GO-TO SECRETOMICS PLATFORM, AND WILL EMPOWER MANY MORE BIOLOGICAL RESEARCHERS TO MEASURE IMPORTANT, SECRETED PROTEINS.

Posted 9/16/22, 12:00 AM